The PLCO model may improve prediction of prostate cancer death at the point of screening. The Stockholm3 test may improve screening itself. A new prostate cancer-specific mortality (PCSM) model may ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Getting screened for prostate cancer may not help you stay alive after all. In a 20-year study of more than 9,000 Swedish men, researchers found no difference in the rate of prostate cancer deaths ...

Obesity Tied to Risk of Prostate Cancer After Negative Biopsy No correlation seen for high levels of metabolic factors and risk of prostate cancer Metabolic factors are not associated with the risk of ...

Prostate cancer screenings slash the risk of dying from the disease in the following decades, according to new research. The screening measures the amount of prostate-specific antigen (PSA) in men’s ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

By Dr. Sanchari Sinha Dutta, Ph.D. New national estimates reveal historic gains in cancer survival and millions of deaths averted, while exposing stark inequities and warning that policy decisions ...